Rare diseases
Investigational molecules
Locations
Back to the Netherlands111 clinical trials in Enschede, The Netherlands across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
The NetherlandsStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
The NetherlandsThe NetherlandsStudy of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
The NetherlandsEffect of Lepodisiran on Coronary Plaque in Adults with Elevated Lipoprotein(a) and Established Atherosclerotic Cardiovascular Disease or High Risk for First Event
The NetherlandsRituximab and venetoclax treatment for 6 vs 26 cycles in patients with relapsed or refractory chronic lymphocytic leukemia
The NetherlandsGB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents
The NetherlandsEvaluation of pembrolizumab and bevacizumab in patients with metastatic cervical cancer
The NetherlandsAn observational study on the use of methotrexate in children and adolescents with Crohn's disease
The NetherlandsA study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.
The NetherlandsStudy of pembrolizumab, capecitabine, or olaparib in patients with early-stage triple negative breast cancer and remaining disease after initial treatment
The NetherlandsA Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on heart failure prevention and treatment of cardiovascular diseases. Studies include evaluation of new therapies for reducing cardiac events and managing arterial conditions.
Research includes novel drug combinations and preventive approaches for high-risk patients.
Comprehensive research in hematologic malignancies and solid tumors, with particular focus on innovative treatment combinations for acute myeloid leukemia and advanced cancers.
Trials evaluate targeted therapies and novel drug combinations to improve patient outcomes.
Studies addressing epileptic conditions and post-cardiac arrest neurological care, including innovative approaches to treating status epilepticus.
Focus on improving neurological outcomes in critical care settings.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
